Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Loading live signals…
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Financial ResultsItem 2.02 · 8-KLOW RiskNeutral
Renovorx, Inc.
renovorx.comFiled: May 14, 2026Los Altos, CACIK: 0001574094Healthcare
AI Executive Summary
AI-powered analysis of 8-K filing content
RenovoRx, Inc. announced Q1 2026 financial results for the quarter ended March 31, 2026, providing investors with insights into the company's operational performance and financial health during the period.
Key Takeaways
Company reported Q1 2026 financial results on May 14, 2026, covering the quarter ended March 31, 2026
Full financial details including revenue figures and key metrics were disclosed in an attached press release (Exhibit 99.1)
1 more takeaway
Filing Overview
Form Type8-K
Filing DateMay 14, 2026
Item2.02
CategoryFinancial Results
CIK0001574094
Accession #0001574094
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings
What This Means
The company is reporting financial results. Look for revenue trends, profitability changes, and forward guidance.